August 2017 – Buhlmann Diagnostics Corp

Month: August 2017

Development of a Robust Automated 384-well Whole Blood Flow Cytometry Assay

Flow CAST®Kinase Inhibition Assay Citation: Wise S. et al. Development of a Robust Automated 384-well Whole Blood Flow Cytometry Assay. SLAS 2014. 3rd Annual Conference & Exhibition. January 18-22, 2014. San Diego, CA Highlights from this Poster "Monitoring basophil activation in whole blood via flow cytometry is an accurate method for measuring a pharmacodynamic response
Continue Reading

Data-Driven Programmatic Approach to Analysis of Basophil Activation Tests

Flow CAST® Assay: Sarita U. Patil et al. Data-Driven Programmatic Approach to Analysis of Basophil Activation Tests Cytometry B Clin Cytom. 2017 Jun 15. doi: 10.1002/cyto.b.21537. PMID: 28618453. Highlights from this Publication Peanut Flow CAST® assay has been the core standardize assay for the first evaluation of  on an automated analysis of Basophil activation test results. Flow CAST® results
Continue Reading

Diagnostic Accuracy of Fecal Calprotectin in Assessing the Severity of Inflammatory Bowel Disease: From Laboratory to Clinic

BÜHLMANN fCAL® ELISA: S. Moein, D. Quujeq et al. Diagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinic. Caspian J Intern Med 2017; 8(3):178-182 DOI: 10.22088/cjim.8.3.178. Highlights from this Publication “ The current study also suggested 78.4 µg/g as the cut-off level for FC by 100% sensitivity and
Continue Reading

Announcing Enhancement to Quantum Blue® fCAL (Calprotectin) High Range Assay

Quantum Blue® fCAL High Range Enhancements BUHLMANN is happy to introduce a revised and enhanced version of our Quantum Blue® fCAL high range test (LF-CHR25) to the market.  The changes result in several beneficial features that not only further simplify the procedure but also improve performance characteristics.   Enhancements and Benefits: Sample dilution NOW in extraction
Continue Reading

Integration of Controls into BUHMANN Quantum Blue® Assays

Quantum Blue® Lateral Flow Assays: Simple, Fast, Accurate Quantitative Results Now Even More Convenient with 2 Lot Specific Ready-to-use Controls! Available NOW with Integrated Controls: Quantum Blue® Infliximab Assay The BÜHLMANN Quantum Blue® Infliximab is the ONLY  quantitative rapid test in the market for infliximab that can provide fast, reliable information for infliximab.  The test is designed for the selective
Continue Reading